Tenon Medical Locks In 1-for-35 Reverse Split to Keep Nasdaq Listing

summarizeSummary

Tenon Medical has finalized a 1-for-35 reverse stock split, effective today, to meet Nasdaq's minimum bid price requirement. The split was approved by shareholders in July and is part of the company's ongoing efforts to maintain its listing amid severe financial distress.

check_boxKey Events · Corporate Governance and Compliance · TNON

• Reverse Stock Split Finalized

  The board locked in a 1-for-35 ratio, effective August 10, 2026, which will proportionally reduce outstanding shares and aim to lift the per-share price above Nasdaq's $1.00 minimum.

• Nasdaq Compliance Effort

  Regaining compliance with Nasdaq's minimum bid price rule is the primary driver of the split, following a delisting notice received in May 2026.

• Shareholder Approval Follow-Through

  Stockholders approved the split at the annual meeting on July 23, 2026, within a previously authorized range of 1-for-2 to 1-for-35.

• No Change to Financial Distress

  The reverse split does not address the company's going-concern warning, cash runway pressure, or the massive dilution authorized in recent months.

auto_awesomeAnalysis · TNON · Industrial Applications And Services

With the final ratio now set at 1-for-35 and the split taking effect today, August 10, 2026, Tenon Medical is executing the plan shareholders greenlit on July 23, 2026. The primary goal is to push the stock price back above Nasdaq's $1.00 minimum bid requirement. While the move proportionally shrinks the outstanding share count, it does nothing to ease the company's underlying financial distress or the massive dilution authorized in recent months. Avoiding delisting is critical, but the pressure on the company remains intense.